Canadian
Cannabis Stocks to Watch; Aphria (TSX: $APH.TO), EVITRADE Health Systems (CSE:
$EVA.C), Lexaria Biosciences (CSE: $LXX.C), Hempco Food and Fiber (TSXV:
$HEMP.V), Aurora Cannabis (TSX: $ACB.TO)
Point
Roberts, WA and Delta, BC - June 14, 2018 (Investorideas.com Newswire)
–Canadian cannabis stocks sector news alert- Investorideas.com, a global
news source and investor resource covering cannabis stocks issues a sector news
alert on Canadian cannabis stocks introducing natural and organic alternatives
to key health issues using cannabinoids. A global revolution is taking place in
healthcare, life sciences and the food and beverage industry with applications
including treatment of anxiety and sleep disorders, pain management, drug
delivery and food supplements.
The
global landscape is changing so rapidly that in some instances, cannabis is now
taking on traditional healthcare at par. Troy Dayton, CEO and Founder of the
Arcview Group, told Investor Ideas at the recently held Arcview Investor Forum
in Vancouver B.C., "What's happening in Germany is very interesting. They
are going to have medical cannabis covered by insurance. Cannabis is actually
going to be on the same playing field as pharmaceuticals."
One Canadian stock ready to capitalize on that is
Aphria Inc. (TSX: APH, US OTC: APHQF).
In May, Aphria announced that its wholly-owned subsidiary Nuuvera
Deutschland GmbH acquired a 25.1% interest in Berlin-based Schöneberg Hospital
("Schöneberg" or the "Hospital"). The acquisition
facilitates Deutschland's long-term strategy to educate German physicians and
patients and advance evidence that supports the effectiveness of medical cannabinoids.
It is also the first step in Deutschland's plans to build and operate pain
treatment centers throughout Germany. The acquisition is valued at €1.2
million.
"With our partnership with Schöneberg, we are
laying the groundwork to be at the forefront of medical services," said
Hendrik Knopp, Managing Director of Deutschland. "We are focused on
bringing a patient-centric approach to medical cannabis in Germany, improving
awareness and education of the therapeutic properties of medical cannabis among
doctors and patients."
"The German market is among the most
attractive opportunities for medical cannabis in the world, and this deal is an
important step towards furthering Deutschland's presence in the country,"
said Vic Neufeld, CEO of Aphria. "Like the clinic model in the Canadian
market, these pain treatment centers will serve an invaluable purpose in
supporting and educating patients, physicians and the German public in the
treatment of pain, including, among other treatments, through the use of medical
cannabis. We are continuing to advance our international strategic plans with
investments such as this that lay the foundation for long-term sustained growth
in every market in which we operate."
Full news: https://ca.finance.yahoo.com/news/aphrias-german-subsidiary-nuuvera-deutschland-120000511.html
Another Canadian company entering the sector has
its origins in natural remedies in healthcare and life sciences, EVITRADE
Health Systems Corp. (CSE:EVA) (OTCQB:AXHLF).
According to
their website: ”The Company is investigating the health effects of various
natural remedies on the health of consumers either alone or in conjunction with
other elements. In focus are various plant-based products that are targeted to
relieve symptoms such as anxiety, sleeplessness, chronic inflammation, fatigue
and high cholesterol. Initial projects will include Astaxanthin, Spirulina and
eventually, Cannabinoids.”
Looking forward, the Company sees additional
potential uses for cannabinoids to include addiction treatment,
anti-inflammatory treatment and epilepsy.
On May 30, 2018, EVITRADE (CSE:EVA) (OTCQB:AXHLF) announced that it had signed a revised Letter of
Intent with Cantech Molecular Research Inc. The soon-to-be acquired Cantech
and/or Cantech Intellectual Property (“IP”) specializes in systems for the
manufacture of highly advanced plants grown through selective breeding (also
known as cultivars) and the production of quality pharmaceutical products for
use in agriculture and medicine.
“With this transaction, the Company is looking to
add yet another valuable and versatile asset in its ongoing bid to become an
influential player in the rapidly growing plant-based pharmaceutical business”,
said C.K. Cheung, CEO.
On May 31, 2018 EVITRADE announced that it made a
voluntary ticker symbol change application with FINRA for the Company’s
quotation on the OTC Markets OTCQB® Venture Market. The symbol is expected to
better reflect the corporate name and its new image. The Company also recently
launched a new website to reflect its expansion in the medical technology,
health and life sciences markets.
EVITRADE continued to offer some insight as to
where it is focussing with the announcement on June 11, 2018; “EVITRADE To
Bring Blockchain Technology to the Hemp Industry”. The Company has signed a Letter of Intent with
Veri-Medical Systems Inc. (“Verimed” or the “Company”) to potentially acquire
the Company which has created a blockchain based “seed-to-sale” protocol
focussed on enhancing the integrity of the sale of Hemp based products such as
cannabidiol (“CBD”).
Cannabis and cannabinoids also offer a new approach
to drug delivery and a Kelowna based company, Lexaria Bioscience Corp. (OTC: LXRP) (CSE: LXX), has developed and out-licensed its disruptive
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules.
On May 31, 2018,
Lexaria announced that, subject
to ongoing legal and tax analysis, it intends to create two wholly-owned
subsidiaries that will respectively hold the intellectual property related to,
in the case of the first subsidiary, the improved processing and
combustion-free delivery of nicotine and nicotine analogs and, in the case of the
second subsidiary, delivery of non-steroidal anti-inflammatory drugs
(''NSAIDs''), phosphodiesterase (''PDE5'') inhibitors and other active
pharmaceutical ingredients.
This proposed structure more suitably reflects the
distinct customer bases and business applications for each subsidiary, thereby
allowing the Company to focus its future research and consider financing
structures and industry partnerships specifically optimized to each. It is
expected that Lexaria's patented DehydraTECHTM technology will be utilized by
both subsidiaries.
Lexaria recently announced lab test results related
to delivery of nicotine through the gastrointestinal tract and superior
nicotine absorption in animal blood plasma.
Lexaria's technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, NSAIDs, PDE5 inhibitors, nicotine and other molecules.
Full news: https://ca.finance.yahoo.com/news/lexaria-bioscience-corp-structures-nicotine-102500495.html
Natural and organic food trends are on the rise
globally; all you have to do is look at the success of Whole Foods, eventually
bought out by Amazon. Hemp’s history with food goes back to the origins of man
and now has a resurgence - thanks to the global legalization trends and new
technology.
For more than 12 years Hempco Food and Fiber Inc. (TSX-V:HEMP) has been a trusted and respected pioneer, innovator and provider of
premier hemp-based foods and hemp nutraceuticals. Aurora Cannabis Inc. (TSX:ACB) (OTCQX:ACBFF) saw the value of the company and owns over 50% of
the Company.
Hempco Food and Fiber recently announced its growth
and expansion plans. The Company has signed a distribution agreement with Tree
of Life, the United Kingdom's leading wholesale distributor of natural and
organic products. Tree of Life serves more than 1,200 retailers in the UK and
more than 30 countries worldwide. The agreement provides Hempco with
significantly increased market reach through Tree of Life's large footprint and
share of shelf space in the health food sector.
The relationship with Tree of Life was driven in
part by the recognition of the strong momentum hemp products continue to
experience in the health food market due to its beneficial properties, such as
omega 3's and high plant-based protein content.
The new Planet Hemp Organic Hemp Seed Oil + CBD
Food Supplement line was successfully launched at Europe's biggest Natural and
Organic products tradeshow on April 22-23, 2018. The show, visited by ten
thousand delegates, including distributors and retailers, was very successful
for the Company, both in terms of raising visibility and in generating commercial
traction. Reception of the new product line was positive, with new orders
received.
The Planet Hemp Organic Hemp Seed Oil + CBD Food
Supplement product line, available in Original, Mint and Orange, is the only
product approved by the Vegan and Vegetarian Societies. This is a rapidly
growing segment of the market, and this validation creates significant
differentiating power for Hempco.
Full news: https://ca.finance.yahoo.com/news/hempco-provides-operational-expansion-growth-135500467.html
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp news
and investing content includes potcastsCM – podcasts featuring cannabis news and stocks to watch plus
insight from thought leaders and experts. Cannabis content also includes
http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a
cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas
directory www.420cannabisinvestorideas.com, and Global
Cannabis Investing at www.Globalcannabisinvesting.com.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country. Disclosure : Investorideas was compensated for
this tag article to include EVITRADE Health Systems Corp.- learn more about
costs and services http://www.investorideas.com/News-Upload/
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment